Recovery of contractility of viable myocardium during inotropic stimulation is not dependent on an increase of myocardial blood flow in the absence of collateral filling

Journal of the American College of Cardiology

Volumn 33, Issue 3, 1999, Pages 697-704

  Barillà, Francesco ^a   De Vincentis, Giuseppe ^a   Mangieri, Enrico ^a   Ciavolella, Massimo ^a   Pannitteri, Gaetano ^a   Scopinaro, Francesco ^a   Critelli, Giuseppe ^a   Campa, Pietro Paolo ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE REVASCULARIZATION; HUMAN; IMAGE ANALYSIS; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIOISOTOPE VENTRICULOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; BLOOD FLOW VELOCITY; CARDIOTONIC AGENTS; COLLATERAL CIRCULATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; DOBUTAMINE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; OBSERVER VARIATION; RADIOPHARMACEUTICALS; STIMULATION, CHEMICAL; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033101752     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00625-1     Document Type: Article

References (38)

1. Pierard LA, De Landsheere CM, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990;5:1021-31.
2. Barillà F, Gheorghiade M, Alam M, Khaja F, Goldstein S. Low-dose dobutamine in patients with acute myocardial infarction identifies viable but not contractile myocardium and predicts the magnitude of improvement in wall motion abnormalities in response to coronary revascularization. Am Heart J 1991;122:1522-31.
3. Smart SC, Sawada SG, Ryan T, et al. Low-dose dobutamine echocardiography detects reversible dysfunction after thrombolytic therapy of acute myocardial infarction. Circulation 1993;88:405-15.
4. Cigarroa CG, deFilippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993;88:430-6.
5. Afridi I, Kleinman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation: optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
6. Meza MF, Kates MA, Barbee WR, et al. Combination of dobutamine and myocardial contrast echocardiography to differentiate postischemic from infarcted myocardium. J Am Coll Cardiol 1997;29:974-84.
7. Sun KT, Czernin J, Lau YK, et al. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism and wall motion in normal and dysfunctional myocardium. Circulation 1996;94:3146-54.
8. Schulz R, Miyazaki S, Miller M, et al. Consequences of regional inotropic stimulation of ischemic myocardium on regional myocardial blood flow and function in anesthetized swine. Circ Res 1989;64:1116-26.
9. Shultz R, Rose J, Martin C, Brodde OE, Heusch G. Development of short-term myocardial hibernation. Its limitation by the severity of ischemia and inotropic stimulation. Circulation 1993;88:684-95.
10. Coma-Canella I, Del Val Gomez Martinez M, Rodrigo F, Castro Beiras JM. The dobutamine stress test with thallium-201 single-photon emission computed tomography and radionuclide angiography: post-infarction study. J Am Coll Cardiol 1993;22:339-406.
11. Saito Y, Yasuno M, Ishida M, et al. Importance of coronary collaterals for restoration of left ventricular function after intracoronary thrombolysis. Am J Cardiol 1985;55:1259-63.
12. Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. Circulation 1991;83:739-46.
13. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992;327:1825-31.
14. Di Carli M, Sherman T, Khanna S, et al. Myocardial viability in asynergic regions subtended by occluded coronary arteries: relation to the status of collateral flow in patients with chronic coronary artery disease. J Am Coll Cardiol 1994;23:860-8.
15. Gillespie TA, Ambos HD, Sobel BE, Roberts R. Effects of dobutamine in patients with acute myocardial infarction. Am J Cardiol 1977;39:588-93.
16. Bolli R, Zhu WX, Myers ML, Hartley CJ, Roberts R. Beta-adrenergic stimulation reverses postischemic myocardial dysfunction without producing subsequent functional deterioration. Am J Cardiol 1985;56:946-8.
17. Buda AJ, Zotz RJ, Gallagher KP. The effect of inotropic stimulation on normal and ischemic myocardium after coronary occlusion. Circulation 1987;76:163-72.
18. Okada RD, Glover D, Gaffney T, Williams S. Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 1988;77:491-8.
19. Gallagher KP, Gerren RA, Ning X-H. The functional border zone in conscious dogs. Circulation 1987;76:929-42.
20. 99mTc-Sestamibi. Circulation 1994;89:2552-61.
21. Verani MS, Jeroudi MO, Mahmarian JJ, et al. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile. J Am Coll Cardiol 1988;12:1573-81.
22. Zhang J, Path G, Chepuri V, et al. Effects of dobutamine on myocardial blood flow, contractile function, and bioenergetic responses distal to coronary stenosis: implication with regard to dobutamine stress testing. Am Heart J 1995;129:330-42.
23. Lee HH, Davila-Roman VG, Ludbrook PA, et al. Dependency of contractile reserve on myocardial blood flow. Implications for the assessment of myocardial viability with dobutamine stress echocardiography. Circulation 1997;96:2884-91.
24. Elhendy A, Cornel JH, Roelandt JRTC, et al. Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction. Am J Cardiol 1997;79:883-8.
25. Elzinga WE, Skinner DB. Hemodynamic characteristics of critical stenosis in canine coronary arteries. J Thorac Cardiovasc Surg 1975;69:217-24.
26. Ball RM, Bache RJ. Distribution of myocardial blood flow in the exercising dog with restricted coronary artery inflow. Circ Res 1976;38:60-6.
27. Gallagher KP, Osakada G, Matsuzaki M, Kemper WS, Ross J Jr. Myocardial blood flow and function with critical coronary stenosis in exercising dogs. Am J Physiol 1982;243:H698-707.
28. Gallagher KP, Folts JD, Shebuski RJ, Rankin GHG, Rowe GG. Subepicardial vasodilator reserve in the presence of critical coronary stenosis in dogs. Am J Cardiol 1980;46:67-73.
29. Gross GJ, Warltier DC. Coronary steal in four models of single or multiple vessel obstruction in dogs. Am J Cardiol 1981;48:84-92.
30. Neill WA, Oxendine J, Phelps N, Anderson RP. Subendocardial ischemia provoked by tachycardia in conscious dogs with coronary stenosis. Am J Cardiol 1975;3:30-6.
31. O'Riordan JB, Flaherty JT, Khuri SF, Brawley RK, Pitt B, Gott LV. Effects of atrial pacing on regional myocardial gas tensions with critical coronary stenosis. Am J Physiol 1977;232:H49-53.
32. Mayer SL, Curry GC, Donsky MS, Twieg DB, Parkey RW, Willerson JT. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol 1976;38:103-8.
33. Guth BD, Schulz R, Thaulow E. Interventricular redistribution of myocardial blood flow during metabolic vasodilation. Pflugers Arch 1991;417:485-92.
34. 99mTc-2-methoxy-isobutylisonitrile. A direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989;79:1282-93.
35. Kiat H, Maddahi J, Roy LT, et al. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods. Am Heart J 1989;117:1-11.
36. Van Train KF, Areeda J, Garcia EV, et al. Quantitative same-day rest-stress technetium-99m-Sestamibi SPECT: definition and validation of stress normal limits and criteria for abnormality. J Nucl Med 1993;34:1494-502.
37. Dilsizian V, Rocco TP, Strauss HW, Boucher CA. Technetium-99m isonitrile myocardial uptake at rest. Relation to severity of coronary stenosis. J Am Coll Cardiol 1989;14:1673-7.
38. 18F]fluorodeoxyglucose. Circulation 1994;89:578-87.